These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3711703)

  • 1. [Evaluation of the protective effects on the ischemic myocardium of coronary perfusion with perfluorochemicals (fluosol-DA)--a comparison with cold blood cardioplegia].
    Ishimaru S; Hirayama T; Uchino T; Hakoshima A; Hino H; Yamada M; Koike S; Furukawa K; Takahashi M; Yoshihama I
    Nihon Kyobu Geka Gakkai Zasshi; 1986 Jan; 34(1):62-8. PubMed ID: 3711703
    [No Abstract]   [Full Text] [Related]  

  • 2. [The protective effects on the myocardium of intermittent coronary perfusion with cold potassium cardioplegia--evaluation by myocardial surface pH].
    Ishimaru S; Hirayama T; Hakoshima A; Hino H; Konishi M; Yamada M; Horiguchi Y; Furukawa K; Takahashi M; Yoshihama I
    Nihon Kyobu Geka Gakkai Zasshi; 1984 Nov; 32(11):1902-9. PubMed ID: 6527050
    [No Abstract]   [Full Text] [Related]  

  • 3. Protection of the hypertrophied pig myocardium. A comparison of crystalloid, blood, and Fluosol-DA cardioplegia during prolonged aortic clamping.
    Novick RJ; Stefaniszyn HJ; Michel RP; Burdon FD; Salerno TA
    J Thorac Cardiovasc Surg; 1985 Apr; 89(4):547-66. PubMed ID: 3157028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluosol cardioplegia--a method of optimizing aerobic metabolism during arrest.
    Rousou JH; Dobbs WA; Engelman RM
    Circulation; 1982 Aug; 66(2 Pt 2):I55-9. PubMed ID: 7083547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Perfluorochemicals (FDA-20%, fluosol), available as cardioplegic solution].
    Nomoto S; Inoue K; Horiuchi M; Yokokawa H; Takaba T; Ishii J
    Kokyu To Junkan; 1985 Nov; 33(11):1355-60. PubMed ID: 4095390
    [No Abstract]   [Full Text] [Related]  

  • 6. Beneficial effect of fluorocarbon reperfusion on postoperative cardiac dysfunction of transplanted heart.
    Ueda K; Genda T; Hirata I; Shimada M; Shibata T; Ueda T; Omoto R
    J Heart Lung Transplant; 1992; 11(4 Pt 1):646-55. PubMed ID: 1498127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of reperfusion after acute coronary occlusion on the beating, working heart compared to the arrested heart treated locally and globally with cardioplegia.
    Franco KL; Uretzky G; Paolini D; Milton G; Cohn LH
    J Thorac Cardiovasc Surg; 1984 Apr; 87(4):561-6. PubMed ID: 6608639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioplegic protection with hypothermic K-Fluosol DA and K/Mg-Fluosol DA solutions.
    Kyösola K; Harjula A; Mattila S; Aalto-Setälä K; Mattila I; Mattila P; Salmenperä M; Merikallio E
    Scand J Thorac Cardiovasc Surg; 1985; 19(3):267-72. PubMed ID: 4081676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of controlled reperfusion after ischemia. XIX. Reperfusate composition: benefits of blood cardioplegia over fluosol DA cardioplegia during regional reperfusion--importance of including blood components in the initial reperfusate.
    Acar C; Partington MT; Buckberg GD
    J Thorac Cardiovasc Surg; 1991 Feb; 101(2):284-93. PubMed ID: 1992239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of a perfluorochemical blood substitute in myocardial preservation].
    Tamura M; Takeuchi S; Takagi I; Kubo Y; Samejima N
    Kokyu To Junkan; 1985 Mar; 33(3):403-10. PubMed ID: 4012069
    [No Abstract]   [Full Text] [Related]  

  • 11. Multidose blood versus crystalloid cardioplegia. Comparison by quantitative assessment of irreversible myocardial injury.
    Feindel CM; Tait GA; Wilson GJ; Klement P; MacGregor DC
    J Thorac Cardiovasc Surg; 1984 Apr; 87(4):585-95. PubMed ID: 6708578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of microfluorometry to cardiovascular surgery. 3. Comparison of crystalloid cardioplegia and cold blood cardioplegia in terms of myocardial metabolism, lipid peroxidation and mitochondrial coenzyme Q10].
    Chiba Y
    Nihon Geka Hokan; 1982 May; 51(3):450-9. PubMed ID: 7138195
    [No Abstract]   [Full Text] [Related]  

  • 13. Superiority of perfluorocarbon cardioplegia over blood or crystalloid cardioplegia.
    Kanter KR; Jaffin JH; Ehrlichman RJ; Flaherty JT; Gott VL; Gardner TJ
    Circulation; 1981 Aug; 64(2 Pt 2):II75-80. PubMed ID: 7249332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved myocardial protection with perfluorocarbon cardioplegia.
    Gardner TJ; Flaherty JT; Kanter KR; Magovern GJ
    Prog Clin Biol Res; 1983; 122():405-17. PubMed ID: 6878379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of synthetic blood and crystalloid cardioplegic solutions on coronary endothelium: an experimental scanning electron microscope study.
    Harjula A; Mattila S; Myllärniemi H; Mattila I; Mattila P; Salmenperä M; Merikallio E
    J Surg Res; 1985 Nov; 39(5):405-12. PubMed ID: 4058003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cold protected hearts extract oxygen from Fluosol-DA during cardiopulmonary bypass.
    Gartman DM; McDonagh PF; Geha AS
    Adv Exp Med Biol; 1984; 180():443-50. PubMed ID: 6534118
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of small-amplitude electrical activity on myocardial preservation in the cold potassium-arrested heart.
    Landymore RW; Marble AE; Trillo A; MacAulay M; Faulkner G; Cameron C
    J Thorac Cardiovasc Surg; 1986 May; 91(5):684-9. PubMed ID: 3702477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Protective effect of Kirsch cardioplegia on the myocardium assessed by electron microscopy and studies on cardiac function (author's transl)].
    Tajima K
    Nihon Kyobu Geka Gakkai Zasshi; 1981 Jul; 29(7):1187-99. PubMed ID: 7299208
    [No Abstract]   [Full Text] [Related]  

  • 19. Fundamental and clinical studies on intracadaveric organ perfusion with Fluosol-DA.
    Honda K
    Prog Clin Biol Res; 1983; 122():327-30. PubMed ID: 6348786
    [No Abstract]   [Full Text] [Related]  

  • 20. Diltiazem cardioplegia. A balance of risk and benefit.
    Christakis GT; Fremes SE; Weisel RD; Tittley JG; Mickle DA; Ivanov J; Madonik MM; Benak AM; McLaughlin PR; Baird RJ
    J Thorac Cardiovasc Surg; 1986 May; 91(5):647-61. PubMed ID: 3517506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.